The phenotypic variability of progressive supranuclear palsy (PSP) may account for its
frequent misdiagnosis, in particular in early stages of the disease. However, large …

Background: PSP is a neuropathologically defined disease entity. Clinical diagnostic criteria,
published in 1996 by the National Institute of Neurological Disorders and Stroke/Society for …

Abstract Background In 2017, the International Parkinson and Movement Disorder Society
put forward new clinical criteria for the diagnosis of PSP, recognizing diverse PSP …

Background Progressive supranuclear palsy (PSP) is a neuropathologically defined disease
presenting with a broad spectrum of clinical phenotypes. Objective To identify clinical …

We assessed the accuracy of clinical diagnosis of progressive supranuclear palsy (PSP,
Steele‐Richardson‐Olszewski disease) and the validity of existing sets of clinical diagnostic …

The clinical heterogeneity of progressive supranuclear palsy (PSP), which is classified as
classic Richardson's syndrome (RS) and PSP‐Parkinsonism (PSP‐P), has been previously …

Background There is currently no undisputed, validated, clinically meaningful measure for
deficits in the broad spectrum of PSP phenotypes. Objective To develop a scale to monitor …

Autopsy is the diagnostic gold standard for progressive supranuclear palsy (PSP). The N
ational I nstitute of N eurological D isorders and S troke and S ociety for P rogressive S …

Abstract Background The Magnetic Resonance Parkinsonism Index is listed as one of the
most reliable imaging morphometric markers for diagnosis of progressive supranuclear …

Abstract We evaluated 16 (15 men, 1 woman) autopsy‐verified progressive supranuclear
palsy (PSP) cases during 31 years (1969–2000) for clinical diagnosis and the course of the …